RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN ® ...
GREENSBORO, N.C., Aug. 2 /PRNewswire/ -- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum ...
IRVINE, Calif., Sep 11, 2008 -- Allergan today announced that it has completed a top-line analysis of its two Phase III clinical trials exploring the use of BOTOX(R) (botulinum toxin type A) for the ...
Most of the public knows of Botox as a quick fix for wrinkles, and a mainstay moneymaker in the world of cosmetic treatment. But botulinum toxin (BTX)—a neurotoxic protein produced by the bacterium ...
-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I have blepharospasm (eye twitching, for those who have ...
Cannabis oil may reduce the duration and frequency of spasms caused by benign essential blepharospasm (eye twitching), researchers say. The treatment could serve as a second-line treatment for ...
MONDAY, April 18, 2016 (HealthDay News) -- Botox is a safe and effective treatment for chronic migraine and three other neurological disorders, an updated guideline from the American Academy of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback